Atherosclerosis after Coronary Artery Bypass Surgery: Results of Recent Studies and Recommendations Regarding Prevention
Authors:
- Martial G. BourassaMBMartial G. Bourassa
- Lucien CampeauLCLucien Campeau
- Jacques LespÉRanceJLJacques LespÉRance
- Charles SolymossCSCharles Solymoss
- 1 January 1986
- journal article
- research article
- Published by S. Karger AG in Cardiology
- Vol. 73 (4-5) , 259-268
Abstract
Atherosclerosis is the most frequent cause of occlusion of aortocoronary saphenous vein grafts between 5 and 10 years after coronary artery bypass surgery. The typical atherosclerotic plaque appears between 1 and 3 years after operation and, at a mean of 5 years, histologic changes of atherosclerosis are present in 21% of grafts and in 27% of patients. Only approximately 60% of saphenous vein grafts remain patent at repeat angiography between 10 and 12 years after bypass surgery; 45% of patent grafts show atherosclerotic changes at angiography and 43% of patients show evidence of atherosclerosis in one or more saphenous vein grafts. We do not know whether the development or the progression of these atherosclerotic changes can be modified; however, the data currently available suggest that the administration of platelet inhibitors and/or of lipid lowering agents offer two promising avenues of investigation in patients undergoing aortocoronary saphenous vein bypass surgery. Until this has been carefully studied, the internal mammary artery should remain the preferred conduit for aortocoronary bypass grafting, whenever possible.Keywords
This publication has 18 references indexed in Scilit:
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984
- THE LIPID RESEARCH CLINICS CORONARY PRIMARY PREVENTION TRIAL RESULTS .2. THE RELATIONSHIP OF REDUCTION IN INCIDENCE OF CORONARY HEART-DISEASE TO CHOLESTEROL LOWERING1984
- Differential Inhibition by Aspirin of Vascular and Platelet Prostaglandin Synthesis in Atherosclerotic PatientsNew England Journal of Medicine, 1983
- A comparison of coronary and internal mammary arteries and implications of the results in the etiology of arteriosclerosisAmerican Heart Journal, 1983
- A Platelet-Inhibitor-Drug Trial in Coronary-Artery Bypass OperationsNew England Journal of Medicine, 1982
- Spasm of a Saphenous Vein Bypass GraftChest, 1981
- Effects of ML-236B (Compactin) on Sterol Synthesis and Low Density Lipoprotein Receptor Activities in Fibroblasts of Patients with Homozygous Familial HypercholesterolemiaJournal of Clinical Investigation, 1981
- Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.Proceedings of the National Academy of Sciences, 1980
- Isolated left anterior descending coronary atherosclerosis: long-term comparison of internal mammary artery and venous autografts.Circulation, 1980
- Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis.Journal of Clinical Investigation, 1976